Instrument Inactif

Autres langues Bavarian Nordic A/S CBOE EUROPE EQUITIES

Actions

DK0015998017

Cours en clôture CBOE EUROPE EQUITIES Autres places de cotation
- ^DKK	-

30/04	Bavarian Nordic enregistre une commande de 65 millions d'euros pour son vaccin antivariolique	MT
29/04	Bavarian Nordic A/S reçoit un contrat de 65 millions d'euros pour la fourniture de vaccins antivarioliques à la réserve stratégique de l'UE	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Bavarian Nordic Books EUR65 Million Order for Smallpox Vaccine	30/04
Bavarian Nordic Receives 65 mEUR Contract to Supply Smallpox Vaccines for EU Strategic Reserve	29/04
Bavarian Nordic A/S Receives EUR 65 Million Contract to Supply Smallpox Vaccines for EU Strategic Reserve	29/04
Bavarian Nordic Starts US Rolling Submission Process for Chikungunya Vaccine Candidate	29/04
Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate	29/04
Bavarian Nordic A/S Initiates Rolling Submission of Biologics License Application with FDA for Chikungunya Vaccine Candidate	29/04
ExpreS2ion to receive approximately SEK 22.5 million dividend payment from AdaptVac ApS	23/04
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such	22/04
OPINIONES DE LOS ANALISTAS DEL DÍA : Acciona, LVMH, Endesa, Viscofan, Easyjet, Repsol, Unibail, Sika, Rio Tinto, Unicredit, ASML...	18/04
Resolutions of the Annual General Meeting 2024 of Bavarian Nordic A/S	16/04
Morris & Dickson is the First U.S. Distributor for Bavarian Nordic's JYNNEOS, the Only FDA-approved Mpox Vaccine	04/04
Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.	02/04
Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.	02/04
Bavarian Nordic A/S : Notice Convening Annual General Meeting	21/03
Bavarian Nordic A/S – Notice Convening Annual General Meeting	21/03
Swiss Regulator Clears Bavarian Nordic’s Jynneos for Smallpox Immunization in Adults	13/03
Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Switzerland	13/03
Bavarian Nordic A/S Receives Approval of Smallpox and Mpox Vaccine in Switzerland	13/03
REPORT OF TRANSACTIONS OF SHARES AND RELATED SECURITIES OF BAVARIAN NORDIC BY PERSONS HOLDING MANAGERIAL RESPONSIBILITIES AND OR PERSONS, COMPANIES CLOSELY ASSOCIATED WITH SUCH	13/03
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such	12/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Bavarian Nordic A/S CBOE EUROPE EQUITIES

Actions

DK0015998017

Autres langues

Filtres